Next Article in Journal
An Update on the Role of Arterial Stiffness in Heart Failure and the Treatment of Dyslipidemia
Next Article in Special Issue
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”
Previous Article in Journal
Reply to Cione et al. Comment on “Moshirfar et al. Accuracy of Six Intraocular Lens Power Calculations in Eyes with Axial Lengths Greater than 28.0 mm. J. Clin. Med. 2022, 11, 5947”
Previous Article in Special Issue
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
 
 
Comment

Article Versions Notes

J. Clin. Med. 2023, 12(9), 3269; https://doi.org/10.3390/jcm12093269
Action Date Notes Link
article xml file uploaded 4 May 2023 08:58 CEST Original file -
article xml uploaded. 4 May 2023 08:58 CEST Update https://www.mdpi.com/2077-0383/12/9/3269/xml
article pdf uploaded. 4 May 2023 08:58 CEST Version of Record https://www.mdpi.com/2077-0383/12/9/3269/pdf
article html file updated 4 May 2023 08:59 CEST Original file https://www.mdpi.com/2077-0383/12/9/3269/html
Back to TopTop